HK/China Healthcare Analyst (ex-Fosun Pharma)

Xinyao (Criss) Wang

Over 15 years' experience in both finance and healthcare, covering clinic operations, investment and equity research in both China and overseas.

Industry Report - Insights on China Pet Medical Industry

Industry Report - Insights on China Medical Beauty Industry

Industry Report - Insights on Hair Loss Prevention and Hair Growth Industry

Battle Lines Drawn As BABA Builds Out First/Last-Mile Capacity; But Who Will Fund 75+ Bn CNY CapEx?

Thematic (Sector/Industry)

Hong kong Pharmaceuticals, biotechnology and life sciences / Thematic (Sector/Industry)

<p>The COVID-19 has affected people's views on the body, and consumers' pursuit of weight control and healthy life has been further strengthened. Meanwhile, the state has vigorously advocated the improvement of national health and continuously introduced relevant supporting policies, which has objectively promoted the continuous improvement of consumers' attention to health. Therefore, in this context, the meal replacement market in China has developed rapidly. With the change of the demand and the development of the industry itself, the audiences have become more extensive. The following mainly provided insights on China meal replacement industry.</p>

The COVID-19 has affected people's views on the body, and consumers' pursuit of weight control and healthy life has been further strengthened. Meanwhile, the state has vigorously advocated the improvement of national health and continuously introduced relevant supporting policies, which has objectively promoted the continuous improvement of consumers' attention to health. Therefore, in this context, the meal replacement market in China has developed rapidly. With the change of the demand and the development of the industry itself, the audiences have become more extensive. The following mainly provided insights on China meal replacement industry.

Industry Report - Insights on China Meal Replacement Industry